BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS

Data supports the expansion of the Early Feasibility Study to 20 patients. HUNTINGTON BEACH, Calif., December 18, 2024--(BUSINESS WIRE)--BiVACOR, a clinical-stage medical device company, announced today, the successful completion of the first phase of the ...